fludarabine and Carcinoma, Hepatocellular

fludarabine has been researched along with Carcinoma, Hepatocellular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Dong, J; Meng, G; Wei, J; Wu, J; Zhang, H; Zhang, Y; Zuo, S1
Chen, L; Chen, M; Chen, W; Zhang, B; Zhang, L; Zhang, Y1
Boyer, SH; Erion, MD; Linemeyer, DL; MacKenna, DA; Montag, A1
Bi, X; Fang, J; Meng, D; Wu, G; Xue, J1
Gati, WP; Kieller, DM; Rahn, JJ; Tyrrell, DL1

Other Studies

5 other study(ies) available for fludarabine and Carcinoma, Hepatocellular

ArticleYear
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
    Cellular oncology (Dordrecht), 2021, Volume: 44, Issue:6

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Immunologic Surveillance; Immunosuppression Therapy; Inflammation; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Oncolytic Viruses; Recombinant Fusion Proteins; Treatment Outcome; Vidarabine; Virus Replication

2021
An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: Carcinoma, Hepatocellular; Gene Transfer Techniques; Genes, Transgenic, Suicide; Green Fluorescent Proteins; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Nanostructures; Purine-Nucleoside Phosphorylase; Ultrasonics; Vidarabine

2018
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cytarabine; Cytochrome P-450 CYP3A; Drug Delivery Systems; Infusions, Intravenous; Liver; Liver Neoplasms; Male; Mice; Nucleosides; Prodrugs; Thymidine; Tissue Distribution; Vidarabine

2009
Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.
    Archives of biochemistry and biophysics, 2007, Dec-01, Volume: 468, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Vascular Endothelial Growth Factor A; Vidarabine

2007
Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5

    Topics: Affinity Labels; Animals; Anti-HIV Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Cells, Cultured; Drug Interactions; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Thioinosine; Thymidine; Tumor Cells, Cultured; Vidarabine; Zalcitabine

1997